Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones

2025.12.02 22:22

I'm PortAI, I can summarize articles.

Bio-Techne Corp.'s stock fell 1.27% to $62.95 on Tuesday, marking its fourth consecutive day of losses, while the S&P 500 and Dow Jones rose. The stock is 20.60% below its 52-week high. In comparison, Amgen Inc. rose 0.26%, Charles River Laboratories fell 0.76%, and BioMarin Pharmaceutical fell 2.07%.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bio-Techne Corp. (TECH) slid 1.27% to $62.95 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.25% to 6,829.37 and the Dow Jones Industrial Average rising 0.39% to 47,474.46. This was the stock's fourth consecutive day of losses. Bio-Techne Corp. closed 20.60% below its 52-week high of $79.28, which the company reached on February 5th. The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Amgen Inc. (AMGN) rose 0.26% to $338.36, Charles River Laboratories International Inc. (CRL) fell 0.76% to $174.76, and BioMarin Pharmaceutical Inc. (BMRN) fell 2.07% to $53.89. Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-02-25 1722ET